Brought to you by 
Trubion Pharmaceuticals completes $48.3mm IPO
12 Oct 2007
Executive Summary
Trubion Pharmaceuticals (cancer and autoimmune disease therapeutics) netted $48.3mm through its initial public offering of 4mm shares at $13 each, the low end of its $13-15 price range.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Trubion Pharmaceuticals completes $48.3mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice